E. Eigenbrodt

5.3k total citations · 1 hit paper
93 papers, 4.3k citations indexed

About

E. Eigenbrodt is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, E. Eigenbrodt has authored 93 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 40 papers in Cancer Research and 20 papers in Biochemistry. Recurrent topics in E. Eigenbrodt's work include Cancer, Hypoxia, and Metabolism (37 papers), Amino Acid Enzymes and Metabolism (20 papers) and Metabolism, Diabetes, and Cancer (20 papers). E. Eigenbrodt is often cited by papers focused on Cancer, Hypoxia, and Metabolism (37 papers), Amino Acid Enzymes and Metabolism (20 papers) and Metabolism, Diabetes, and Cancer (20 papers). E. Eigenbrodt collaborates with scholars based in Germany, Austria and United States. E. Eigenbrodt's co-authors include Sybille Mazurek, C. B. Boschek, F Hugo, Werner Zwerschke, Pidder Jansen‐Dürr, S. Mazurek, M. Reinacher, H. Grimm, Wilhelm Schoner and Robert R. Friis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

E. Eigenbrodt

92 papers receiving 4.1k citations

Hit Papers

Pyruvate kinase type M2 and its role in tumor growth and ... 2005 2026 2012 2019 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Eigenbrodt Germany 38 2.9k 2.1k 780 464 397 93 4.3k
R. Brooks Robey United States 24 3.4k 1.2× 1.8k 0.9× 524 0.7× 379 0.8× 355 0.9× 47 4.7k
Dipak Panigrahy United States 26 2.4k 0.8× 1.4k 0.7× 772 1.0× 460 1.0× 444 1.1× 45 4.5k
Ellen S. Pizer United States 33 3.1k 1.0× 2.5k 1.2× 760 1.0× 148 0.3× 444 1.1× 42 5.2k
Tzuling Cheng United States 10 3.1k 1.1× 1.9k 0.9× 603 0.8× 426 0.9× 526 1.3× 15 4.3k
Joanne K. Kelleher United States 31 3.7k 1.3× 1.7k 0.8× 223 0.3× 627 1.4× 293 0.7× 78 4.9k
Bailin Zhang China 21 2.1k 0.7× 1.0k 0.5× 627 0.8× 375 0.8× 407 1.0× 93 3.7k
George Simos Greece 44 4.1k 1.4× 1.5k 0.7× 488 0.6× 314 0.7× 303 0.8× 98 5.3k
Martin O. Bergö Sweden 41 5.0k 1.7× 927 0.4× 947 1.2× 629 1.4× 403 1.0× 106 6.8k
Warren S.‐L. Liao United States 38 3.1k 1.1× 1.2k 0.5× 1.1k 1.4× 412 0.9× 645 1.6× 79 5.0k
Sophie Vasseur France 36 2.6k 0.9× 1.7k 0.8× 1.4k 1.8× 199 0.4× 403 1.0× 60 4.6k

Countries citing papers authored by E. Eigenbrodt

Since Specialization
Citations

This map shows the geographic impact of E. Eigenbrodt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Eigenbrodt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Eigenbrodt more than expected).

Fields of papers citing papers by E. Eigenbrodt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Eigenbrodt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Eigenbrodt. The network helps show where E. Eigenbrodt may publish in the future.

Co-authorship network of co-authors of E. Eigenbrodt

This figure shows the co-authorship network connecting the top 25 collaborators of E. Eigenbrodt. A scholar is included among the top collaborators of E. Eigenbrodt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Eigenbrodt. E. Eigenbrodt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mazurek, Sybille, C. B. Boschek, F Hugo, & E. Eigenbrodt. (2005). Pyruvate kinase type M2 and its role in tumor growth and spreading. Seminars in Cancer Biology. 15(4). 300–308. 670 indexed citations breakdown →
2.
Klett, R., et al.. (2004). Value of tumor M2-PK in thyroid carcinoma: a pilot study.. PubMed. 23(6D). 5237–40. 2 indexed citations
3.
Schneider, Joachim, et al.. (2003). Tumor M2-pyruvate kinase in the follow-up of inoperable lung cancer patients: a pilot study. Cancer Letters. 193(1). 91–98. 33 indexed citations
4.
Mazurek, S., H. Grimm, C. B. Boschek, Peter Vaupel, & E. Eigenbrodt. (2002). Pyruvate kinase type M2: a crossroad in the tumor metabolome. British Journal Of Nutrition. 87(S1). S23–S29. 130 indexed citations
6.
Schneider, Joachim, et al.. (2001). Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer.. PubMed. 20(6D). 5053–8. 59 indexed citations
7.
Wenisch, Sabine, Ernst Lücker, E. Eigenbrodt, M. Bülte, & R. Leiser. (2000). Procedures for the detection of unwanted ingredients in meat products with regard to BSE. 4. Histological and immunohistological procedures for the detection of central nervous system tissue in meat products.. ˜Die œFleischwirtschaft. 80(7). 69–72. 1 indexed citations
8.
Lücker, Ernst, et al.. (2000). Procedures for detecting unwanted ingredients in meat products with regard to BSE. 3. Detection of central nervous system tissue.. ˜Die œFleischwirtschaft. 80(5). 74–77.
9.
Hugo, F, G. Fischer, & E. Eigenbrodt. (1999). Quantitative detection of tumor M2-PK in serum and plasma.. PubMed. 19(4A). 2753–7. 23 indexed citations
10.
Oremek, G. M., Stefan Teigelkamp, Wolfgang Kramer, E. Eigenbrodt, & K.-H. Usadel. (1999). The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma.. PubMed. 19(4A). 2599–601. 43 indexed citations
11.
Steinberg, Pablo, et al.. (1999). Expression of pyruvate kinase M 2 in preneoplastic hepatic foci of N -nitrosomorpholine-treated rats. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 434(3). 213–220. 49 indexed citations
12.
Mazurek, S., C. B. Boschek, & E. Eigenbrodt. (1997). The Role of Phosphometabolites in Cell Proliferation, Energy Metabolism, and Tumor Therapy. Journal of Bioenergetics and Biomembranes. 29(4). 315–330. 122 indexed citations
13.
Brinck, Ulrich, G. Fischer, E. Eigenbrodt, M. J. Oehmke, & S. Mazurek. (1994). L- and M2- pyruvate kinase expression in renal cell carcinomas and their metastases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 424(2). 177–85. 66 indexed citations
14.
Braun, Annika, E. Eigenbrodt, R. J. Laib, & H. Brunn. (1991). Hepatocarcinogenicity of PCB congeners. Toxicological & Environmental Chemistry Reviews. 34(1). 23–28. 4 indexed citations
15.
Eigenbrodt, E., et al.. (1989). Study of Nafenopin, a Hypolipidemic Drug on Liver Metabolism. Archives of toxicology. Supplement. 13. 304–308. 1 indexed citations
16.
Fischer, G., et al.. (1987). Immunohistochemical demonstration of decreased L-pyruvate kinase in enzyme altered rat liver lesions produced by different carcinogens. Virchows Archiv B Cell Pathology Including Molecular Pathology. 53(1). 359–364. 15 indexed citations
17.
Ruschenburg, I, et al.. (1987). Decrease in glucokinase and glucose-6-phosphatase and increase in hexokinase in putative preneoplastic lesions of rat liver. Journal of Cancer Research and Clinical Oncology. 113(5). 430–436. 24 indexed citations
18.
Eigenbrodt, E. & M. Reinacher. (1986). Carbohydrate Metabolism in Neoplastic Tissue. Transfusion Medicine and Hemotherapy. 13(2). 85–90. 1 indexed citations
19.
Reinacher, M., E. Eigenbrodt, I. Timmermann-Trosiener, et al.. (1986). Pyruvate kinase isoenzymes in altered foci and carcinoma of rat liver. Carcinogenesis. 7(8). 1351–1357. 16 indexed citations
20.
Schering, Beate, E. Eigenbrodt, Dietmar Linder, & Wilhelm Schoner. (1982). Purification and properties of pyruvate kinase type M2 from rat lung. Biochimica et Biophysica Acta (BBA) - General Subjects. 717(2). 337–347. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026